Telomerase and the astragalus connection
Telomeres are the protective caps on chromosome ends that shorten with each cell division, and telomerase is the enzyme that can rebuild them. Astragaloside IV, a compound isolated from Astragalus membranaceus and the basis of the commercial product known as TA-65, has been studied as a modest activator of telomerase, principally in immune cell populations where telomere maintenance affects how long those cells stay functional.
The proposed mechanism is an upregulation of telomerase activity, which in laboratory and some human-cell studies has been associated with slowing or partly offsetting the telomere shortening that accompanies cellular aging.
How strong the evidence really is
The effect reported is modest, much of the supporting work is in cell and small human studies, and a telomerase change is a biomarker, not a demonstrated extension of healthy lifespan or a treatment for any disease. Activating telomerase also raises theoretical concerns that researchers continue to examine, since the same enzyme is exploited by some cancers.
This is general educational information, not medical advice, and astragalus does not treat or cure any condition. It can interact with immunosuppressants and other drugs, so consult a qualified professional before use.